PBMs in the Senate hot seat as bipartisan transparency measures may take root

Pharmacy benefit managers ⁠— the much-maligned middlemen of the pharmaceutical supply chain ⁠— took the brunt of questioning from senators on both sides of the aisle on Thursday at a commerce committee hearing.